Related Experiment Video
Updated: Aug 15, 2026

Imaging and Analysis of Neurofilament Transport in Excised Mouse Tibial Nerve
Published on: August 31, 2020
Effect of GSK-3 overactivation on neurofilament phosphorylation
Juan Chen1, Jie Zhou, Youmei Feng
1Department of Biochemistry and Molecular Biology, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
Abstract:
In this study, we studied the effect of glycogen synthase kinase-3 (GSK-3) overactivation on neurofilament phosphorylation in cultured cells. After N2a cells were treated with the specific inhibitor (wortmannin) of phosphoinositol-3 kinase (PI-3K) or treated with wortmannin and the specific inhibitor (LiCl) of glycogen synthase kinase-3 (GSK-3), GSK-3 activity and neurofilament phosphorylation were detected by using GSK-3 activity assay, Western blots and immunofluoresence. Our results showed that after treatment of N2a cells with wortmannin for 1 h, overactivation of GSK-3 caused a reduced staining with antibody SMI32 and an enhanced staining with antibody SMI31. When N2a cells were treated with wortmannin and LiCl, the activity of GSK-3 was reduced substantially. At the same time, the phosphorylation of neurofilament was also reduced. The study demonstrated that overactivation of GSK-3 induced hyperphosphorylation of neurofilament and suggested that in vitro overactivation of GSK-3 resulted in neurofilament hyperphosphorylation and this may be the underlying mechanism for Alzheimer's disease.
Insights
Overactivating glycogen synthase kinase-3 (GSK-3) in cells leads to neurofilament hyperphosphorylation. This finding suggests a potential mechanism contributing to Alzheimer's disease pathology.
Area of Science:
- Neuroscience
- Cell Biology
- Biochemistry
Background:
- Glycogen synthase kinase-3 (GSK-3) plays a role in cellular processes.
- Dysregulation of GSK-3 is implicated in neurodegenerative diseases.
- Neurofilament phosphorylation is altered in neurological disorders.
Purpose of the Study:
- To investigate the impact of GSK-3 overactivation on neurofilament phosphorylation in cultured N2a cells.
- To explore the potential link between GSK-3 activity and neurofilament hyperphosphorylation.
- To determine if GSK-3 overactivation is a contributing factor to Alzheimer's disease mechanisms.
Main Methods:
- Utilized N2a cells for in vitro studies.
- Employed wortmannin, a phosphoinositol-3 kinase (PI-3K) inhibitor, to induce GSK-3 overactivation.
- Used LiCl, a GSK-3 inhibitor, in combination with wortmannin.
- Assessed GSK-3 activity using a GSK-3 activity assay.
- Analyzed neurofilament phosphorylation levels via Western blots and immunofluorescence with antibodies SMI31 and SMI32.
Main Results:
- Wortmannin treatment for 1 hour resulted in GSK-3 overactivation.
- Overactivated GSK-3 led to reduced SMI32 staining and enhanced SMI31 staining, indicating altered phosphorylation.
- Inhibition of GSK-3 with LiCl significantly reduced GSK-3 activity and subsequent neurofilament phosphorylation.
- Demonstrated a direct correlation between GSK-3 overactivation and neurofilament hyperphosphorylation.
Conclusions:
- Overactivation of GSK-3 induces neurofilament hyperphosphorylation in cultured cells.
- This in vitro finding suggests a potential underlying mechanism for neurofilament pathology observed in Alzheimer's disease.
- GSK-3 emerges as a key target for understanding and potentially treating Alzheimer's disease-related neurodegeneration.
More Related Videos
Related Concept Videos
Actin Filament Depolymerization
In F-actin, the ADF/cofilin proteins...
Generation of Straight or Branched Actin Filaments
Arp2/3 Complex
Arp2/3 complex is a seven-subunit complex consisting of two proteins similar to actin- Arp2 and Arp3, and five other subunits that help keep Arp2 and Arp3 inactive. When required, the complex is...
Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
GPCRs Regulate Adenylyl Cylase Activity
Two...

